BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Solbiati L, Ierace T, Tonolini M, Cova L. Guidance and monitoring of radiofrequency liver tumor ablation with contrast-enhanced ultrasound. Eur J Radiol. 2004;51 Suppl:S19-S23. [PMID: 15311434 DOI: 10.1016/j.ejrad.2004.03.035] [Cited by in Crossref: 133] [Cited by in F6Publishing: 104] [Article Influence: 7.8] [Reference Citation Analysis]
Number Citing Articles
1 Solomon SB, Silverman SG. Imaging in interventional oncology. Radiology. 2010;257:624-640. [PMID: 21084414 DOI: 10.1148/radiol.10081490] [Cited by in Crossref: 58] [Cited by in F6Publishing: 39] [Article Influence: 5.8] [Reference Citation Analysis]
2 Ettorre GM, Laurenzi A. Other “Bridge” Therapies for Liver Transplantation: RFA, TACE, and TARE. In: Cillo U, De Carlis L, editors. Liver Transplantation and Hepatobiliary Surgery. Cham: Springer International Publishing; 2020. pp. 183-91. [DOI: 10.1007/978-3-030-19762-9_19] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Zheng SG, Xu HX, Lu MD, Xie XY, Xu ZF, Liu GJ, Liu LN. Role of contrast-enhanced ultrasound in follow-up assessment after ablation for hepatocellular carcinoma. World J Gastroenterol. 2013;19:855-865. [PMID: 23430451 DOI: 10.3748/wjg.v19.i6.855] [Cited by in CrossRef: 21] [Cited by in F6Publishing: 17] [Article Influence: 3.0] [Reference Citation Analysis]
4 Lencioni R, Della Pina C, Cioni D, Crocetti L, Bartolozzi C. European Guidelines in Liver Contrast Ultrasound. In: Lencioni R, editor. Enhancing the Role of Ultrasound with Contrast Agents. Milano: Springer Milan; 2006. pp. 105-16. [DOI: 10.1007/88-470-0476-4_9] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
5 Roccarina D, Garcovich M, Ainora ME, Riccardi L, Pompili M, Gasbarrini A, Zocco MA. Usefulness of contrast enhanced ultrasound in monitoring therapeutic response after hepatocellular carcinoma treatment. World J Hepatol 2015;7:1866-74. [PMID: 26207168 DOI: 10.4254/wjh.v7.i14.1866] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 3.0] [Reference Citation Analysis]
6 Rhim H, Lee MH, Kim Y, Choi D, Lee WJ, Lim HK. Planning Sonography to Assess the Feasibility of Percutaneous Radiofrequency Ablation of Hepatocellular Carcinomas. American Journal of Roentgenology 2008;190:1324-30. [DOI: 10.2214/ajr.07.2970] [Cited by in Crossref: 72] [Cited by in F6Publishing: 22] [Article Influence: 5.5] [Reference Citation Analysis]
7 da Silva NPB, Beyer L, Hottenrott M, Hackl C, Schlitt H, Stroszczynski C, Wiggermann P, Jung E. Efficiency of contrast enhanced ultrasound for immediate assessment of ablation status after intraoperative radiofrequency ablation of hepatic malignancies. CH 2017;66:357-68. [DOI: 10.3233/ch-179112] [Cited by in Crossref: 10] [Cited by in F6Publishing: 1] [Article Influence: 2.5] [Reference Citation Analysis]
8 Frühling P, Nilsson A, Duraj F, Haglund U, Norén A. Single-center nonrandomized clinical trial to assess the safety and efficacy of irreversible electroporation (IRE) ablation of liver tumors in humans: Short to mid-term results. Eur J Surg Oncol 2017;43:751-7. [PMID: 28109674 DOI: 10.1016/j.ejso.2016.12.004] [Cited by in Crossref: 34] [Cited by in F6Publishing: 27] [Article Influence: 8.5] [Reference Citation Analysis]
9 El-Kady NM, Esmat G, Mahmoud EH, Darweesh SK, Mahmoud SH, Elagawy WA. Hypertonic saline-enhanced radiofrequency versus chemoembolization sequential radiofrequency in the treatment of large hepatocellular carcinoma. Eur J Gastroenterol Hepatol 2013;25:628-33. [PMID: 23325283 DOI: 10.1097/MEG.0b013e32835d2c4f] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
10 Lencioni R, Della Pina C, Crocetti L, Bozzi E, Cioni D. Clinical management of focal liver lesions: the key role of real-time contrast-enhanced US. Eur Radiol Suppl 2007;17:73-9. [DOI: 10.1007/s10406-007-0231-8] [Cited by in Crossref: 35] [Cited by in F6Publishing: 30] [Article Influence: 2.7] [Reference Citation Analysis]
11 Cathomas M, Mertineit N, Kim-Fuchs C, Lachenmayer A, Maurer MH. Value of MRI/CT Image Fusion for Targeting "invisible" Lesions in Stereotactic Microwave Ablation (SMWA) of Malignant Liver Lesions: A Retrospective Analysis. Cardiovasc Intervent Radiol 2020;43:1505-14. [PMID: 32642989 DOI: 10.1007/s00270-020-02565-8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
12 Wang C, Geng X, Yeh T, Liu H, Tsui P. Monitoring radiofrequency ablation with ultrasound Nakagami imaging: Monitoring ablation with ultrasound. Med Phys 2013;40:072901. [DOI: 10.1118/1.4808115] [Cited by in Crossref: 26] [Cited by in F6Publishing: 13] [Article Influence: 3.3] [Reference Citation Analysis]
13 Meloni MF, Andreano A, Laeseke PF, Livraghi T, Sironi S, Lee FT Jr. Breast cancer liver metastases: US-guided percutaneous radiofrequency ablation--intermediate and long-term survival rates. Radiology 2009;253:861-9. [PMID: 19709994 DOI: 10.1148/radiol.2533081968] [Cited by in Crossref: 83] [Cited by in F6Publishing: 68] [Article Influence: 6.9] [Reference Citation Analysis]
14 Wu JY, Chen MH, Yang W, Lin SZ, Wu W, Yin SS, Zhang H, Yan K. Role of contrast enhanced ultrasound in radiofrequency ablation of metastatic liver carcinoma. Chin J Cancer Res 2012;24:44-51. [PMID: 23359761 DOI: 10.1007/s11670-012-0044-8] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.1] [Reference Citation Analysis]
15 Vincenot J, Melodelima D, Chavrier F, Vignot A, Kocot A, Chapelon J. Electronic Beam Steering Used with a Toroidal HIFU Transducer Substantially Increases the Coagulated Volume. Ultrasound in Medicine & Biology 2013;39:1241-54. [DOI: 10.1016/j.ultrasmedbio.2013.01.019] [Cited by in Crossref: 23] [Cited by in F6Publishing: 13] [Article Influence: 2.9] [Reference Citation Analysis]
16 Solmi L, Nigro G, Roda E. Therapeutic effectiveness of echo-guided percutaneous radiofrequency ablation therapy with a LeVeen needle electrode in hepatocellular carcinoma. World J Gastroenterol 2006;12:1098-104. [PMID: 16534852 DOI: 10.3748/wjg.v12.i7.1098] [Cited by in CrossRef: 17] [Cited by in F6Publishing: 17] [Article Influence: 1.1] [Reference Citation Analysis]
17 Liu LN, Xu HX, Zhang YF, Xu JM. Hepatocellular carcinoma after ablation: the imaging follow-up scheme. World J Gastroenterol. 2013;19:797-801. [PMID: 23429970 DOI: 10.3748/wjg.v19.i6.797] [Cited by in CrossRef: 10] [Cited by in F6Publishing: 12] [Article Influence: 1.4] [Reference Citation Analysis]
18 Joosten J, Ruers T. Local radiofrequency ablation techniques for liver metastases of colorectal cancer. Crit Rev Oncol Hematol. 2007;62:153-163. [PMID: 17317204 DOI: 10.1016/j.critrevonc.2006.12.001] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
19 Bathe OF, Mahallati H, Sutherland F, Dixon E, Pasieka J, Sutherland G. Complex hepatic surgery aided by a 1.5-tesla moveable magnetic resonance imaging system. The American Journal of Surgery 2006;191:598-603. [DOI: 10.1016/j.amjsurg.2006.02.008] [Cited by in Crossref: 8] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
20 Salvaggio G, Campisi A, Lo Greco V, Cannella I, Meloni MF, Caruso G. Evaluation of posttreatment response of hepatocellular carcinoma: comparison of ultrasonography with second-generation ultrasound contrast agent and multidetector CT. Abdom Imaging. 2010;35:447-453. [PMID: 19562414 DOI: 10.1007/s00261-009-9551-6] [Cited by in Crossref: 42] [Cited by in F6Publishing: 40] [Article Influence: 3.5] [Reference Citation Analysis]
21 Zhou Y, Yang Y, Zhou B, Wang Z, Zhu R, Chen X, Ouyang J, Li Q, Zhou J. Challenges Facing Percutaneous Ablation in the Treatment of Hepatocellular Carcinoma: Extension of Ablation Criteria. J Hepatocell Carcinoma 2021;8:625-44. [PMID: 34189133 DOI: 10.2147/JHC.S298709] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
22 Tanis E, Spliethoff J, Evers D, Langhout G, Snaebjornsson P, Prevoo W, Hendriks B, Ruers T. Real-time in vivo assessment of radiofrequency ablation of human colorectal liver metastases using diffuse reflectance spectroscopy. European Journal of Surgical Oncology (EJSO) 2016;42:251-9. [DOI: 10.1016/j.ejso.2015.12.005] [Cited by in Crossref: 22] [Cited by in F6Publishing: 17] [Article Influence: 4.4] [Reference Citation Analysis]
23 Minami Y, Kudo M. Review of dynamic contrast-enhanced ultrasound guidance in ablation therapy for hepatocellular carcinoma. World J Gastroenterol 2011;17:4952-9. [PMID: 22174544 DOI: 10.3748/wjg.v17.i45.4952] [Cited by in CrossRef: 34] [Cited by in F6Publishing: 33] [Article Influence: 3.8] [Reference Citation Analysis]
24 Lee JY, Choi BI, Han JK, Lee JM, Kim SH. State-of-the-art ultrasonography of hepatocellular carcinoma. European Journal of Radiology 2006;58:177-85. [DOI: 10.1016/j.ejrad.2005.11.038] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
25 Kang H, Kim JH, Lee SM, Yang HK, Ahn SJ, Han JK. Additional value of contrast-enhanced ultrasonography for fusion-guided, percutaneous biopsies of focal liver lesions: prospective feasibility study. Abdom Radiol 2018;43:3279-87. [DOI: 10.1007/s00261-018-1608-y] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
26 Mauri G, Nicosia L, Varano GM, Shyn P, Sartori S, Tombesi P, Di Vece F, Orsi F, Solbiati L. Unusual tumour ablations: report of difficult and interesting cases. Ecancermedicalscience 2017;11:733. [PMID: 28487751 DOI: 10.3332/ecancer.2017.733] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 1.8] [Reference Citation Analysis]
27 Bathe OF, Mahallati H. MR-guided ablation of hepatocellular carcinoma aided by gadoxetic acid. J Surg Oncol 2007;95:670-3. [DOI: 10.1002/jso.20768] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
28 Alzaraa A, Gravante G, Chung WY, Al-Leswas D, Morgan B, Dennison A, Lloyd D. Contrast-enhanced ultrasound in the preoperative, intraoperative and postoperative assessment of liver lesions. Hepatol Res 2013;43:809-19. [PMID: 23745715 DOI: 10.1111/hepr.12044] [Cited by in Crossref: 26] [Cited by in F6Publishing: 21] [Article Influence: 3.3] [Reference Citation Analysis]
29 Di Costanzo GG, Francica G, Pacella CM. Laser ablation for small hepatocellular carcinoma: State of the art and future perspectives. World J Hepatol. 2014;6:704-715. [PMID: 25349642 DOI: 10.4254/wjh.v6.i10.704] [Cited by in Crossref: 37] [Cited by in F6Publishing: 17] [Article Influence: 5.3] [Reference Citation Analysis]
30 Chiorean L, Tana C, Braden B, Caraiani C, Sparchez Z, Cui XW, Baum U, Dietrich CF. Advantages and Limitations of Focal Liver Lesion Assessment with Ultrasound Contrast Agents: Comments on the European Federation of Societies for Ultrasound in Medicine and Biology (EFSUMB) Guidelines. Med Princ Pract. 2016;25:399-407. [PMID: 27318740 DOI: 10.1159/000447670] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 4.2] [Reference Citation Analysis]
31 Gallotti A, D’Onofrio M, Ruzzenente A, Martone E, De Robertis R, Guglielmi A, Pozzi Mucelli R. Contrast-enhanced ultrasonography (CEUS) immediately after percutaneous ablation of hepatocellular carcinoma. Radiol Med. 2009;114:1094-1105. [PMID: 19756947 DOI: 10.1007/s11547-009-0436-0] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 1.3] [Reference Citation Analysis]
32 Kim AY, Lee MW, Rhim H, Cha DI, Choi D, Kim YS, Lim HK, Cho SW. Pretreatment evaluation with contrast-enhanced ultrasonography for percutaneous radiofrequency ablation of hepatocellular carcinomas with poor conspicuity on conventional ultrasonography. Korean J Radiol 2013;14:754-63. [PMID: 24043968 DOI: 10.3348/kjr.2013.14.5.754] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 1.9] [Reference Citation Analysis]
33 Zheng Y, Zhang Y, Ao M, Zhang P, Zhang H, Li P, Qing L, Wang Z, Ran H. Hematoporphyrin encapsulated PLGA microbubble for contrast enhanced ultrasound imaging and sonodynamic therapy. J Microencapsul 2012;29:437-44. [PMID: 22299595 DOI: 10.3109/02652048.2012.655333] [Cited by in Crossref: 23] [Cited by in F6Publishing: 17] [Article Influence: 2.6] [Reference Citation Analysis]
34 Eisele RM, Schumacher G, Lopez-Hänninen E, Neuhaus P. Role of B-mode ultrasound screening in detection of local tumor recurrence in the first year after radiofrequency ablation in the liver. Cancer Detect Prev 2007;31:316-22. [PMID: 17935909 DOI: 10.1016/j.cdp.2007.07.002] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
35 Nicolau C, Vilana R, Bianchi L, Brú C. Early-stage hepatocellular carcinoma: the high accuracy of real-time contrast-enhanced ultrasonography in the assessment of response to percutaneous treatment. Eur Radiol Suppl 2007;17:80-8. [DOI: 10.1007/s10406-007-0232-7] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 1.0] [Reference Citation Analysis]
36 Rempp H, Unterberg J, Hoffmann R, Pereira PL, Schick F, Claussen CD, Clasen S. Therapy monitoring of magnetic resonance-guided radiofrequency ablation using T1- and T2-weighted sequences at 1.5 T: reliability of estimated ablation zones. Invest Radiol 2013;48:429-36. [PMID: 23511192 DOI: 10.1097/RLI.0b013e318280b007] [Cited by in Crossref: 8] [Cited by in F6Publishing: 2] [Article Influence: 1.1] [Reference Citation Analysis]
37 Jun HY, Ryu JH, Byun SJ, Jeong CW, Kim TH, Lee YH, Yoon KH. Combined Radiofrequency Ablation and Double Anti-Angiogenic Protein Therapy to Increase Coagulation Efficacy: An Experimental Study in a Murine Renal Carcinoma Model. Korean J Radiol 2015;16:776-82. [PMID: 26175576 DOI: 10.3348/kjr.2015.16.4.776] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 1.2] [Reference Citation Analysis]
38 Mauri G, Porazzi E, Cova L, Restelli U, Tondolo T, Bonfanti M, Cerri A, Ierace T, Croce D, Solbiati L. Intraprocedural contrast-enhanced ultrasound (CEUS) in liver percutaneous radiofrequency ablation: clinical impact and health technology assessment. Insights Imaging. 2014;5:209-216. [PMID: 24563244 DOI: 10.1007/s13244-014-0315-7] [Cited by in Crossref: 87] [Cited by in F6Publishing: 73] [Article Influence: 12.4] [Reference Citation Analysis]
39 Vallone P, Catalano O, Izzo F, Siani A. Combined ethanol injection therapy and radiofrequency ablation therapy in percutaneous treatment of hepatocellular carcinoma larger than 4 cm. Cardiovasc Intervent Radiol 2006;29:544-51. [PMID: 16528626 DOI: 10.1007/s00270-005-0173-2] [Cited by in Crossref: 23] [Cited by in F6Publishing: 16] [Article Influence: 1.5] [Reference Citation Analysis]
40 Kono Y, Lucidarme O, Choi S, Rose SC, Hassanein TI, Alpert E, Mattrey RF. Contrast-enhanced Ultrasound as a Predictor of Treatment Efficacy within 2 Weeks after Transarterial Chemoembolization of Hepatocellular Carcinoma. Journal of Vascular and Interventional Radiology 2007;18:57-65. [DOI: 10.1016/j.jvir.2006.10.016] [Cited by in Crossref: 46] [Cited by in F6Publishing: 43] [Article Influence: 3.3] [Reference Citation Analysis]
41 Fahey BJ, Nelson RC, Hsu SJ, Bradway DP, Dumont DM, Trahey GE. In vivo guidance and assessment of liver radio-frequency ablation with acoustic radiation force elastography. Ultrasound Med Biol. 2008;34:1590-1603. [PMID: 18471954 DOI: 10.1016/j.ultrasmedbio.2008.03.006] [Cited by in Crossref: 44] [Cited by in F6Publishing: 31] [Article Influence: 3.4] [Reference Citation Analysis]
42 Parmentier H, Melodelima D, N'Djin A, Chesnais S, Chapelon JY, Rivoire M. High-intensity focused ultrasound ablation for the treatment of colorectal liver metastases during an open procedure: study on the pig. Ann Surg. 2009;249:129-136. [PMID: 19106688 DOI: 10.1097/sla.0b013e31818c70b6] [Cited by in Crossref: 32] [Cited by in F6Publishing: 5] [Article Influence: 2.7] [Reference Citation Analysis]
43 Bale R, Widmann G, Stoffner DI. Stereotaxy: breaking the limits of current radiofrequency ablation techniques. Eur J Radiol. 2010;75:32-36. [PMID: 20452738 DOI: 10.1016/j.ejrad.2010.04.013] [Cited by in Crossref: 46] [Cited by in F6Publishing: 35] [Article Influence: 4.2] [Reference Citation Analysis]
44 Lepetit-coiffé M, Quesson B, Seror O, Dumont E, Le Bail B, Moonen CTW, Trillaud H. Real-time monitoring of radiofrequency ablation of rabbit liver by respiratory-gated quantitative temperature MRI. J Magn Reson Imaging 2006;24:152-9. [DOI: 10.1002/jmri.20605] [Cited by in Crossref: 47] [Cited by in F6Publishing: 35] [Article Influence: 3.1] [Reference Citation Analysis]
45 Zhang D, Liang W, Zhang M, Liang P, Gu Y, Kuang M, Cao F, Yu X, Liu F, Yu J. Multiple antenna placement in microwave ablation assisted by a three-dimensional fusion image navigation system for hepatocellular carcinoma. International Journal of Hyperthermia 2018;35:122-32. [DOI: 10.1080/02656736.2018.1484183] [Cited by in Crossref: 10] [Cited by in F6Publishing: 4] [Article Influence: 3.3] [Reference Citation Analysis]
46 Chen MH, Yang W, Yan K, Dai Y, Wu W, Fan ZH, Callstrom MR, Charboneau JW. The role of contrast-enhanced ultrasound in planning treatment protocols for hepatocellular carcinoma before radiofrequency ablation. Clin Radiol. 2007;62:752-760. [PMID: 17604763 DOI: 10.1016/j.crad.2006.12.013] [Cited by in Crossref: 21] [Cited by in F6Publishing: 17] [Article Influence: 1.5] [Reference Citation Analysis]
47 Fahey BJ, Hsu SJ, Wolf PD, Nelson RC, Trahey GE. Liver ablation guidance with acoustic radiation force impulse imaging: challenges and opportunities. Phys Med Biol. 2006;51:3785-3808. [PMID: 16861781 DOI: 10.1088/0031-9155/51/15/013] [Cited by in Crossref: 47] [Cited by in F6Publishing: 34] [Article Influence: 3.1] [Reference Citation Analysis]
48 Uggowitzer MM, Gotschuli G, Reiter H, Petek B. Kontrastverst�rkte Sonographie der Leber. Radiologe 2005;45:24-33. [DOI: 10.1007/s00117-004-1138-1] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
49 Tacher V, Le Deley M, Hollebecque A, Deschamps F, Vielh P, Hakime A, Ileana E, Abedi-ardekani B, Charpy C, Massard C, Rosellini S, Gajda D, Celebic A, Ferté C, Ngo-camus M, Gouissem S, Koubi-pick V, Andre F, Vassal G, Deandreis D, Lacroix L, Soria J, De Baère T. Factors associated with success of image-guided tumour biopsies: Results from a prospective molecular triage study (MOSCATO-01). European Journal of Cancer 2016;59:79-89. [DOI: 10.1016/j.ejca.2016.02.006] [Cited by in Crossref: 22] [Cited by in F6Publishing: 17] [Article Influence: 4.4] [Reference Citation Analysis]
50 Jiang J, Brace C, Andreano A, DeWall RJ, Rubert N, Fisher TG, Varghese T, Lee F Jr, Hall TJ. Ultrasound-based relative elastic modulus imaging for visualizing thermal ablation zones in a porcine model. Phys Med Biol 2010;55:2281-306. [PMID: 20354279 DOI: 10.1088/0031-9155/55/8/011] [Cited by in Crossref: 20] [Cited by in F6Publishing: 13] [Article Influence: 1.8] [Reference Citation Analysis]
51 Tanis E, Nordlinger B, Mauer M, Sorbye H, van Coevorden F, Gruenberger T, Schlag PM, Punt CJ, Ledermann J, Ruers TJ. Local recurrence rates after radiofrequency ablation or resection of colorectal liver metastases. Analysis of the European Organisation for Research and Treatment of Cancer #40004 and #40983. Eur J Cancer. 2014;50:912-919. [PMID: 24411080 DOI: 10.1016/j.ejca.2013.12.008] [Cited by in Crossref: 101] [Cited by in F6Publishing: 79] [Article Influence: 14.4] [Reference Citation Analysis]
52 Cosgrove D, Harvey C. Clinical uses of microbubbles in diagnosis and treatment. Med Biol Eng Comput. 2009;47:813-826. [PMID: 19205774 DOI: 10.1007/s11517-009-0434-3] [Cited by in Crossref: 82] [Cited by in F6Publishing: 51] [Article Influence: 6.8] [Reference Citation Analysis]
53 Malone CD, Fetzer DT, Monsky WL, Itani M, Mellnick VM, Velez PA, Middleton WD, Averkiou MA, Ramaswamy RS. Contrast-enhanced US for the Interventional Radiologist: Current and Emerging Applications.Radiographics. 2020;40:562-588. [PMID: 32125955 DOI: 10.1148/rg.2020190183] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 8.0] [Reference Citation Analysis]
54 Wu R, Luo Y, Tang J, Yang M, Li J, Zhang Y, Zhang M. Ultrasound-guided radiofrequency ablation for papillary thyroid microcarcinoma: a retrospective analysis of 198 patients. Int J Hyperthermia 2020;37:168-74. [PMID: 32026736 DOI: 10.1080/02656736.2019.1708480] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 16.0] [Reference Citation Analysis]
55 Herbst EB, Unnikrishnan S, Wang S, Klibanov AL, Hossack JA, Mauldin FW Jr. The Use of Acoustic Radiation Force Decorrelation-Weighted Pulse Inversion for Enhanced Ultrasound Contrast Imaging. Invest Radiol 2017;52:95-102. [PMID: 27495188 DOI: 10.1097/RLI.0000000000000313] [Cited by in Crossref: 10] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
56 Lee MW, Lim HK, Kim YJ, Choi D, Kim Y, Lee WJ, Cha DI, Park MJ, Rhim H. Percutaneous Sonographically Guided Radio Frequency Ablation of Hepatocellular Carcinoma: Causes of Mistargeting and Factors Affecting the Feasibility of a Second Ablation Session. Journal of Ultrasound in Medicine 2011;30:607-15. [DOI: 10.7863/jum.2011.30.5.607] [Cited by in Crossref: 28] [Cited by in F6Publishing: 25] [Article Influence: 2.8] [Reference Citation Analysis]
57 Kono Y, Mattrey RF. Ultrasound of the liver. Radiol Clin North Am. 2005;43:815-826, vii. [PMID: 16098341 DOI: 10.1016/j.rcl.2005.05.007] [Cited by in Crossref: 11] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
58 Gu X, Zhong H, Wan M, Hu X, Lv D, Shen L, Zhang X. Parametric perfusion imaging based on low-cost ultrasound platform. Ultrasound Med Biol 2010;36:130-44. [PMID: 19931972 DOI: 10.1016/j.ultrasmedbio.2009.09.002] [Cited by in Crossref: 16] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
59 Koda M, Mandai M, Matono T, Sugihara T, Nagahara T, Ueki M, Ohyama K, Hosho K, Murawaki Y. Assessment of the ablated area after radiofrequency ablation by contrast-enhanced sonography; comparison with virtual sonography with magnetic navigation. Clinical Imaging 2010;34:60-4. [DOI: 10.1016/j.clinimag.2009.03.006] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
60 Wu H, Patel RB, Zheng Y, Solorio L, Krupka TM, Ziats NP, Haaga JR, Exner AA. Differentiation of benign periablational enhancement from residual tumor following radio-frequency ablation using contrast-enhanced ultrasonography in a rat subcutaneous colon cancer model. Ultrasound Med Biol 2012;38:443-53. [PMID: 22266229 DOI: 10.1016/j.ultrasmedbio.2011.12.008] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
61 Filippiadis DK, Velonakis G, Kelekis A, Sofocleous CT. The Role of Percutaneous Ablation in the Management of Colorectal Cancer Liver Metastatic Disease. Diagnostics (Basel) 2021;11:308. [PMID: 33672993 DOI: 10.3390/diagnostics11020308] [Reference Citation Analysis]
62 Surveillance group. ; Diagnosis group; Staging group; Surgery group; Local ablation group; TACE/TARE/HAI group; Target therapy/systemic therapy group; Radiotherapy group; Prevention group; Drafting group. Management consensus guideline for hepatocellular carcinoma: 2016 updated by the Taiwan Liver Cancer Association and the Gastroenterological Society of Taiwan. J Formos Med Assoc. 2018;117:381-403. [PMID: 29074347 DOI: 10.1016/j.jfma.2017.09.007] [Cited by in Crossref: 47] [Cited by in F6Publishing: 38] [Article Influence: 11.8] [Reference Citation Analysis]
63 Ohmoto K, Yoshioka N, Tomiyama Y, Shibata N, Kawase T, Yoshida K, Kuboki M, Yamamoto S. CO2-enhanced sonographically guided radiofrequency ablation and transcatheter arterial chemoembolization for small hepatocellular carcinoma poorly defined on conventional sonography. J Clin Ultrasound 2007;35:78-81. [PMID: 17195192 DOI: 10.1002/jcu.20273] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
64 Cornelis FH, Petre EN, Vakiani E, Klimstra D, Durack JC, Gonen M, Osborne J, Solomon SB, Sofocleous CT. Immediate Postablation 18F-FDG Injection and Corresponding SUV Are Surrogate Biomarkers of Local Tumor Progression After Thermal Ablation of Colorectal Carcinoma Liver Metastases. J Nucl Med 2018;59:1360-5. [PMID: 29439012 DOI: 10.2967/jnumed.117.194506] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 5.0] [Reference Citation Analysis]
65 Sato KT, Wang D, Lewandowski RJ, Ryu RK, Klein RA, Salem R, Larson AC, Omary RA. Four-dimensional transcatheter intraarterial perfusion MRI monitoring of radiofrequency ablation of rabbit VX2 liver tumors. J Magn Reson Imaging 2011;34:563-9. [PMID: 21761464 DOI: 10.1002/jmri.22644] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
66 Bartolotta TV, Taibbi A, Midiri M, De Maria M. Hepatocellular cancer response to radiofrequency tumor ablation: contrast-enhanced ultrasound. Abdom Imaging. 2008;33:501-511. [PMID: 17786507 DOI: 10.1007/s00261-007-9294-1] [Cited by in Crossref: 32] [Cited by in F6Publishing: 33] [Article Influence: 2.5] [Reference Citation Analysis]
67 Du J, Li HL, Zhai B, Chang S, Li FH. Radiofrequency ablation for hepatocellular carcinoma: utility of conventional ultrasound and contrast-enhanced ultrasound in guiding and assessing early therapeutic response and short-term follow-up results. Ultrasound Med Biol 2015;41:2400-11. [PMID: 26055968 DOI: 10.1016/j.ultrasmedbio.2015.05.004] [Cited by in Crossref: 25] [Cited by in F6Publishing: 19] [Article Influence: 4.2] [Reference Citation Analysis]
68 Prada F, Perin A, Martegani A, Aiani L, Solbiati L, Lamperti M, Casali C, Legnani F, Mattei L, Saladino A, Saini M, DiMeco F. Intraoperative contrast-enhanced ultrasound for brain tumor surgery. Neurosurgery 2014;74:542-52; discussion 552. [PMID: 24598809 DOI: 10.1227/NEU.0000000000000301] [Cited by in Crossref: 106] [Cited by in F6Publishing: 28] [Article Influence: 15.1] [Reference Citation Analysis]
69 Salvatore V, Bolondi L. Clinical impact of ultrasound-related techniques on the diagnosis of focal liver lesions. Liver Cancer. 2012;1:238-246. [PMID: 24159588 DOI: 10.1159/000343838] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 1.9] [Reference Citation Analysis]
70 Chan AK, Hegarty C, Klass D, Yoshida E, Chung S, Liu DM, Ho SG, Harris AC. The Role of Contrast-Enhanced Ultrasound in Guiding Radiofrequency Ablation of Hepatocellular Carcinoma. Can Assoc Radiol J 2015;66:171-8. [DOI: 10.1016/j.carj.2014.11.005] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 3.0] [Reference Citation Analysis]
71 Mauri G, Cova L, De Beni S, Ierace T, Tondolo T, Cerri A, Goldberg SN, Solbiati L. Real-time US-CT/MRI image fusion for guidance of thermal ablation of liver tumors undetectable with US: results in 295 cases. Cardiovasc Intervent Radiol. 2015;38:143-151. [PMID: 24806953 DOI: 10.1007/s00270-014-0897-y] [Cited by in Crossref: 119] [Cited by in F6Publishing: 95] [Article Influence: 17.0] [Reference Citation Analysis]
72 Wu H, Wilkins LR, Ziats NP, Haaga JR, Exner AA. Real-time monitoring of radiofrequency ablation and postablation assessment: accuracy of contrast-enhanced US in experimental rat liver model. Radiology 2014;270:107-16. [PMID: 23912621 DOI: 10.1148/radiol.13121999] [Cited by in Crossref: 37] [Cited by in F6Publishing: 33] [Article Influence: 4.6] [Reference Citation Analysis]
73 Viganò L, Laurenzi A, Solbiati L, Procopio F, Cherqui D, Torzilli G. Open Liver Resection, Laparoscopic Liver Resection, and Percutaneous Thermal Ablation for Patients with Solitary Small Hepatocellular Carcinoma (≤30 mm): Review of the Literature and Proposal for a Therapeutic Strategy. Dig Surg 2018;35:359-71. [PMID: 29890512 DOI: 10.1159/000489836] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 3.7] [Reference Citation Analysis]
74 Wink MH, Wijkstra H, De La Rosette JJMCH, Grimbergen CA. Ultrasound imaging and contrast agents: A safe alternative to MRI? Minimally Invasive Therapy & Allied Technologies 2009;15:93-100. [DOI: 10.1080/13645700600674252] [Cited by in Crossref: 31] [Cited by in F6Publishing: 21] [Article Influence: 2.6] [Reference Citation Analysis]
75 Nicolau Molina C, Fontanilla Echeveste T, Del Cura Rodríguez JL, Cruz Villalón F, Ripollés González T, Baudet Naveros B, Velasco Marcos MA, Garre Sánchez C, Huertas Arroyo R, Hernández García L. [Usefulness of contrast-enhanced ultrasonography in daily clinical practice: a multicenter study in Spain]. Radiologia. 2010;52:144-152. [PMID: 20044114 DOI: 10.1016/j.rx.2009.11.005] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
76 Shah DR, Green S, Elliot A, McGahan JP, Khatri VP. Current oncologic applications of radiofrequency ablation therapies. World J Gastrointest Oncol. 2013;5:71-80. [PMID: 23671734 DOI: 10.4251/wjgo.v5.i4.71] [Cited by in CrossRef: 33] [Cited by in F6Publishing: 25] [Article Influence: 4.1] [Reference Citation Analysis]
77 Rajesh S, Mukund A, Arora A, Jain D, Sarin SK. Contrast-enhanced US-guided Radiofrequency Ablation of Hepatocellular Carcinoma. Journal of Vascular and Interventional Radiology 2013;24:1235-40. [DOI: 10.1016/j.jvir.2013.04.013] [Cited by in Crossref: 22] [Cited by in F6Publishing: 17] [Article Influence: 2.8] [Reference Citation Analysis]
78 N'Djin WA, Melodelima D, Schenone F, Rivoire M, Chapelon JY. Assisted hepatic resection using a toroidal HIFU device: an in vivo comparative study in pig. Med Phys 2011;38:1769-78. [PMID: 21626911 DOI: 10.1118/1.3551985] [Cited by in Crossref: 19] [Cited by in F6Publishing: 13] [Article Influence: 1.9] [Reference Citation Analysis]
79 Lencioni R. Impact of European Federation of Societies for Ultrasound in Medicine and Biology (EFSUMB) guidelines on the use of contrast agents in liver ultrasound. Eur Radiol 2006;16:1610-3. [DOI: 10.1007/s00330-005-0123-z] [Cited by in Crossref: 27] [Cited by in F6Publishing: 24] [Article Influence: 1.8] [Reference Citation Analysis]
80 Kapoor A, Kapoor A, Mahajan G. Technical note: Radiofrequency ablation of hepatocellular carcinoma with contrast-enhanced ultrasound guidance: First Indian experience. Indian J Radiol Imaging 2011;21:121-3. [PMID: 21799595 DOI: 10.4103/0971-3026.82296] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
81 Vilana R, Bianchi L, Varela M, Nicolau C, Sánchez M, Ayuso C, García M, Sala M, Llovet JM, Bruix J. Is microbubble-enhanced ultrasonography sufficient for assessment of response to percutaneous treatment in patients with early hepatocellular carcinoma? Eur Radiol. 2006;16:2454-2462. [PMID: 16710666 DOI: 10.1007/s00330-006-0264-8] [Cited by in Crossref: 77] [Cited by in F6Publishing: 63] [Article Influence: 5.1] [Reference Citation Analysis]
82 Rettenbacher T. Focal liver lesions: role of contrast-enhanced ultrasound. Eur J Radiol. 2007;64:173-182. [PMID: 17900841 DOI: 10.1016/j.ejrad.2007.07.026] [Cited by in Crossref: 38] [Cited by in F6Publishing: 32] [Article Influence: 2.7] [Reference Citation Analysis]
83 Eyding J, Fung C, Niesen WD, Krogias C. Twenty Years of Cerebral Ultrasound Perfusion Imaging-Is the Best yet to Come? J Clin Med 2020;9:E816. [PMID: 32192077 DOI: 10.3390/jcm9030816] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
84 Zhao D, Shao YQ, Hu J, Liu D, Tang W, He N. Role of contrast-enhanced ultrasound guidance in core-needle biopsy for diagnosis of cervical tuberculous lymphadenitis. Clin Hemorheol Microcirc 2021;77:381-9. [PMID: 33337357 DOI: 10.3233/CH-201038] [Reference Citation Analysis]
85 Jakimowicz JJ. Intraoperative ultrasonography in open and laparoscopic abdominal surgery: an overview. Surg Endosc 2006;20:S425-35. [DOI: 10.1007/s00464-006-0035-2] [Cited by in Crossref: 31] [Cited by in F6Publishing: 20] [Article Influence: 2.1] [Reference Citation Analysis]
86 Lepetit-coiffé M, Laumonier H, Seror O, Quesson B, Sesay M, Moonen CTW, Grenier N, Trillaud H. Real-time monitoring of radiofrequency ablation of liver tumors using thermal-dose calculation by MR temperature imaging: initial results in nine patients, including follow-up. Eur Radiol 2010;20:193-201. [DOI: 10.1007/s00330-009-1532-1] [Cited by in Crossref: 51] [Cited by in F6Publishing: 24] [Article Influence: 4.3] [Reference Citation Analysis]
87 Geng X, Zhou Z, Li Q, Wu S, Wang C, Liu H, Chuang C, Tsui P. Comparison of ultrasound temperature imaging with infrared thermometry during radio frequency ablation. Jpn J Appl Phys 2014;53:047001. [DOI: 10.7567/jjap.53.047001] [Cited by in Crossref: 7] [Article Influence: 1.0] [Reference Citation Analysis]
88 Wiesinger I, Beyer LP, Zausig N, Verloh N, Wiggermann P, Stroszczynski C, Jung EM. Evaluation of integrated color-coded perfusion analysis for contrast-enhanced ultrasound (CEUS) after percutaneous interventions for malignant liver lesions: First results. Clin Hemorheol Microcirc 2018;69:59-67. [PMID: 29758936 DOI: 10.3233/CH-189131] [Cited by in Crossref: 16] [Cited by in F6Publishing: 2] [Article Influence: 5.3] [Reference Citation Analysis]
89 Guenette JP, Dupuy DE. Radiofrequency ablation of colorectal hepatic metastases. J Surg Oncol. 2010;102:978-987. [PMID: 21166002 DOI: 10.1002/jso.21658] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 1.8] [Reference Citation Analysis]
90 DeWall RJ, Varghese T, Brace CL. Quantifying local stiffness variations in radiofrequency ablations with dynamic indentation. IEEE Trans Biomed Eng 2012;59:728-35. [PMID: 22167553 DOI: 10.1109/TBME.2011.2178848] [Cited by in Crossref: 13] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
91 Xu HX. Contrast-enhanced ultrasound: The evolving applications. World J Radiol 2009;1:15-24. [PMID: 21160717 DOI: 10.4329/wjr.v1.i1.15] [Cited by in CrossRef: 44] [Cited by in F6Publishing: 38] [Article Influence: 4.4] [Reference Citation Analysis]
92 Parikh A, Taouli B. Imaging of hepatocellular carcinoma: current concepts. Recent Results Cancer Res. 2013;190:33-55. [PMID: 22941012 DOI: 10.1007/978-3-642-16037-0_3] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
93 Kim JE, Kim YS, Rhim H, Lim HK, Lee MW, Choi D, Shin SW, Cho SK. Outcomes of patients with hepatocellular carcinoma referred for percutaneous radiofrequency ablation at a tertiary center: analysis focused on the feasibility with the use of ultrasonography guidance. Eur J Radiol. 2011;79:e80-e84. [PMID: 21514757 DOI: 10.1016/j.ejrad.2011.03.090] [Cited by in Crossref: 54] [Cited by in F6Publishing: 46] [Article Influence: 5.4] [Reference Citation Analysis]
94 Rempp H, Waibel L, Hoffmann R, Claussen CD, Pereira PL, Clasen S. MR-guided radiofrequency ablation using a wide-bore 1.5-T MR system: clinical results of 213 treated liver lesions. Eur Radiol 2012;22:1972-82. [DOI: 10.1007/s00330-012-2438-x] [Cited by in Crossref: 26] [Cited by in F6Publishing: 21] [Article Influence: 2.9] [Reference Citation Analysis]
95 Laganà D, Carrafiello G, Mangini M, Lumia D, Mocciardini L, Chini C, Pinotti G, Cuffari S, Fugazzola C. Hepatic radiofrequency under CT-fluoroscopy guidance. Radiol med 2008;113:87-100. [DOI: 10.1007/s11547-008-0224-2] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 0.8] [Reference Citation Analysis]
96 Mauri G, Gennaro N, De Beni S, Ierace T, Goldberg SN, Rodari M, Solbiati LA. Real-Time US-18FDG-PET/CT Image Fusion for Guidance of Thermal Ablation of 18FDG-PET-Positive Liver Metastases: The Added Value of Contrast Enhancement. Cardiovasc Intervent Radiol 2019;42:60-8. [PMID: 30288593 DOI: 10.1007/s00270-018-2082-1] [Cited by in Crossref: 23] [Cited by in F6Publishing: 16] [Article Influence: 7.7] [Reference Citation Analysis]
97 Chen M, Wu W, Yang W, Dai Y, Gao W, Yin S, Yan K. The Use of Contrast-Enhanced Ultrasonography in the Selection of Patients With Hepatocellular Carcinoma for Radio Frequency Ablation Therapy. Journal of Ultrasound in Medicine 2007;26:1055-63. [DOI: 10.7863/jum.2007.26.8.1055] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 1.1] [Reference Citation Analysis]
98 Liu D, Brace CL. Evaluation of tissue deformation during radiofrequency and microwave ablation procedures: Influence of output energy delivery. Med Phys 2019;46:4127-34. [PMID: 31260115 DOI: 10.1002/mp.13688] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
99 de Senneville BD, Mougenot C, Quesson B, Dragonu I, Grenier N, Moonen CT. MR thermometry for monitoring tumor ablation. Eur Radiol 2007;17:2401-10. [PMID: 17701184 DOI: 10.1007/s00330-007-0646-6] [Cited by in Crossref: 104] [Cited by in F6Publishing: 69] [Article Influence: 7.4] [Reference Citation Analysis]
100 Delorme S, Krix M. Contrast-enhanced ultrasound for examining tumor biology. Cancer Imaging 2006;6:148-52. [PMID: 17015239 DOI: 10.1102/1470-7330.2006.0023] [Cited by in Crossref: 42] [Cited by in F6Publishing: 27] [Article Influence: 2.8] [Reference Citation Analysis]
101 Su Z, Li K, Xu E, Wu L, Wang X, Li L, Wang J, Lin P, Chen Y, Zhang Y, Li J, Dufour C, Mory B, Zheng R. A clinical validation study for the feasibility and reliability of three-dimensional ultrasound-ultrasound automatic image registration. International Journal of Hyperthermia 2015;31:875-82. [DOI: 10.3109/02656736.2015.1073370] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
102 O’Rourke AP, Haemmerich D, Prakash P, Converse MC, Mahvi DM, Webster JG. Current status of liver tumor ablation devices. Expert Rev Med Devices. 2007;4:523-537. [PMID: 17605688 DOI: 10.1586/17434440.4.4.523] [Cited by in Crossref: 47] [Cited by in F6Publishing: 21] [Article Influence: 3.6] [Reference Citation Analysis]
103 Adams R. Intraoperative Ultrasound of the Liver: Techniques for Liver Resection and Transplantation. Surgery of the Liver, Biliary Tract and Pancreas. Elsevier; 2007. pp. 1484-524. [DOI: 10.1016/b978-1-4160-3256-4.50106-x] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
104 Lu MD, Yu XL, Li AH, Jiang TA, Chen MH, Zhao BZ, Zhou XD, Wang JR. Comparison of contrast enhanced ultrasound and contrast enhanced CT or MRI in monitoring percutaneous thermal ablation procedure in patients with hepatocellular carcinoma: a multi-center study in China. Ultrasound Med Biol. 2007;33:1736-1749. [PMID: 17629608 DOI: 10.1016/j.ultrasmedbio.2007.05.004] [Cited by in Crossref: 66] [Cited by in F6Publishing: 60] [Article Influence: 4.7] [Reference Citation Analysis]